Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome

被引:54
作者
Grasemann, H
Gärtig, SS
Wiesemann, HG
Teschler, H
Konietzko, N
Ratjen, F
机构
[1] Univ Essen Gesamthsch, Childrens Hosp, Essen, Germany
[2] Univ Essen Gesamthsch, Ruhrlandklin, Essen, Germany
关键词
cystic fibrosis; L-arginine; nitric oxide; primary ciliary dyskinesia syndrome;
D O I
10.1183/09031936.99.13111499
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Airway nitric oxide concentrations in patients with cystic fibrosis or primary ciliary dyskinesia syndrome have been shown to be lower than in healthy subjects. Decreased NO concentrations ma contribute to impaired ciliary clearance, respiratory tract infections, or obstructive lung disease in these conditions. Nasal and exhaled NO concentrations were compared before and after infusion of 500 mg.kg(-1) L-arginine, the substrate of NO synthases, in 11 cystic fibrosis (CF) patients, seven primary ciliary dyskinesia (PCD) syndrome patients, and 11 control subjects. Baseline nasal and exhaled NO concentrations were significantly low er in both CF and PCD syndrome patients than in controls (p<0.01). In controls, the maximum increase of NO was seen immediately after L-arginine infusion in the upper airways (1.8-fold) and 3 h after the infusion in the lower airways (1.6-fold. Although NO concentrations also increased significantly in both CF (1.9-fold and 1.6-fold, respectively) and PCD syndrome patients (1.4-fold and 1.8-fold. respectively), concentrations remained subnormal compared with baseline values of controls. Pulmonary function remained unchanged in both patient groups. In conclusion, the low airway nitric oxide formation in both cystic fibrosis and primary ciliary dyskinesia syndrome patients can be augmented by L-arginine administration. The finding that pulmonary function remained unchanged in both conditions may be due to the fact that normalization of airway nitric oxide concentrations could not be achieved.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 31 条
[1]  
ALVING K, 1993, EUR RESPIR J, V6, P1368
[2]  
[Anonymous], IMMUNOLOGY TODAY
[3]   CONSTITUTIVE AND INDUCIBLE NITRIC-OXIDE SYNTHASE GENE-EXPRESSION, REGULATION, AND ACTIVITY IN HUMAN LUNG EPITHELIAL-CELLS [J].
ASANO, K ;
CHEE, CBE ;
GASTON, B ;
LILLY, CM ;
GERARD, C ;
DRAZEN, JM ;
STAMLER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10089-10093
[4]   Reduced upper airway nitric oxide in cystic fibrosis [J].
BalfourLynn, IM ;
Laverty, A ;
Dinwiddie, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (04) :319-322
[5]   NITRIC-OXIDE AND LUNG-DISEASE [J].
BARNES, PJ ;
BELVISI, MG .
THORAX, 1993, 48 (10) :1034-1043
[6]  
BOAT TF, 1996, NELSON TXB PEDIAT, P1251
[7]  
BOAT TF, 1996, NELSON TXB PEDIAT, P1239
[8]   ACTIVATION OF CFTR CHLORIDE CURRENT BY NITRIC-OXIDE IN HUMAN T-LYMPHOCYTES [J].
DONG, YJ ;
CHAO, AC ;
KOUYAMA, K ;
HSU, YP ;
BOCIAN, RC ;
MOSS, RB ;
GARDNER, P .
EMBO JOURNAL, 1995, 14 (12) :2700-2707
[9]   BRONCHODILATOR ACTION OF INHALED NITRIC-OXIDE IN GUINEA-PIGS [J].
DUPUY, PM ;
SHORE, SA ;
DRAZEN, JM ;
FROSTELL, C ;
HILL, WA ;
ZAPOL, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :421-428
[10]   Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man - Correlation with neuropeptides [J].
Fischer, A ;
Hoffmann, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (01) :209-216